{"filing": {"accession": "0001493152-26-028460", "cik": "0001763950", "ticker": "LTRN", "company_name": "Lantern Pharma Inc.", "form_type": "S-1", "filing_type": "S-1", "filing_date": "2026-06-12", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315226028460/0001493152-26-028460-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1763950/000149315226028460/0001493152-26-028460-index.htm", "period_of_report": null}, "html_url": "/api/filings/000149315226028460/stream", "exhibits": [], "sections": [{"section_name": "part_2", "section_title": "Part II", "start_position": 74091, "end_position": 89967}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware283446-3973463"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "Large\n accelerated filer \u2610Accelerated\n filer \u2610"}, {"table_index": 4, "table_type": "exhibit_index", "caption": null, "header_text": "ABOUT THIS PROSPECTUSii"}, {"table_index": 9, "table_type": "exhibit_index", "caption": null, "header_text": "Common\n stock offered by selling stockholders2,242,719\n shares, representing shares issuable upon the exercise of warrants held by the selling stockholders."}, {"table_index": 13, "table_type": "financial", "caption": null, "header_text": "\u25cfgeneral\n economic and market conditions and other factors, including factors unrelated to our operating\n performance, such adverse impact of tariffs and any trade war, rising inflation and disruption"}, {"table_index": 15, "table_type": "financial", "caption": null, "header_text": "\u25cfthe\n existence of substantial doubt regarding our ability to continue as a going concern in the\n absence of obtaining substantial additional funding;"}, {"table_index": 19, "table_type": "text", "caption": null, "header_text": "Beneficially\n OwnedBefore OfferingShares ofCommon Stock OfferedBeneficially Owned After Offering(1)"}, {"table_index": 21, "table_type": "text", "caption": null, "header_text": "(1)Assumes\n that all of the shares of common stock being registered by this prospectus are resold by\n the selling stockholders to third parties."}, {"table_index": 35, "table_type": "text", "caption": null, "header_text": "\u25cfin\n \u201cat the market offerings\u201d within the meaning of Rule 415(a)(4) under the Securities\n Act, to or through a market maker or into an existing trading market, on an exchange or otherwise;"}, {"table_index": 37, "table_type": "text", "caption": null, "header_text": "\u25cbin\n one or more transactions at a fixed price or prices, which may be changed from time to time;"}, {"table_index": 39, "table_type": "text", "caption": null, "header_text": "\u25cbon\n a national securities exchange;"}, {"table_index": 40, "table_type": "text", "caption": null, "header_text": "\u25cfenter\n into option or other transactions with broker-dealers or other financial institutions which\n require the delivery to them of the shares of common stock covered by this prospectus, which\n they "}, {"table_index": 43, "table_type": "text", "caption": null, "header_text": "\u25cfthe\n number of shares of common stock involved in the arrangement;"}, {"table_index": 55, "table_type": "financial", "caption": null, "header_text": "SEC registration fee$1,207.91"}, {"table_index": 57, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit\n No.Description"}, {"table_index": 59, "table_type": "text", "caption": null, "header_text": "(i)To\n include any prospectus required by Section 10(a)(3) of the Securities Act;"}, {"table_index": 62, "table_type": "text", "caption": null, "header_text": "Lantern\n Pharma Inc."}, {"table_index": 63, "table_type": "text", "caption": null, "header_text": "NameTitleDate"}], "exhibits_pending": true, "cdn_html": true, "response_time_ms": 26}